Immediate Impact

3 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Rheumatoid arthritis
2023 Standout
2 intermediate papers

Works of Lucy Rowell being referenced

A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
2013

Author Peers

Author Last Decade Papers Cites
Lucy Rowell 465 223 122 271 243 31 1.1k
S. Radominski 483 239 36 117 136 53 932
Andrea Becciolini 710 371 94 148 41 57 1.3k
Šárka Forejtová 1001 399 26 205 62 32 1.4k
Mathias Grünke 654 632 67 143 38 39 1.4k
John Percy 509 255 15 149 58 46 1.1k
Tatiana Cobo‐Ibáñez 1021 429 24 80 78 40 1.4k
Karin Manger 725 523 87 78 39 30 1.2k
Marcel D. Posthumus 656 338 76 147 23 30 1.4k
P. L. C. M. van Riel 916 276 25 67 68 25 1.3k
Elena Massarotti 675 520 150 101 24 31 1.3k

All Works

Loading papers...

Rankless by CCL
2026